Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_provenance.
- NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_assertion description "[The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_provenance.
- NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_assertion evidence source_evidence_literature NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_provenance.
- NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_assertion SIO_000772 24131622 NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_provenance.
- NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_assertion wasDerivedFrom befree-20150227 NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_provenance.
- NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_assertion wasGeneratedBy ECO_0000203 NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP675769.RADlfmOg96RX7qPppnIBMnheZjKbwUQer3wzbcb1WQfbc130_provenance.